ARCHIVES

FDA Official Outlines agency’s Views On Efficacy Requirement

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Policy: silicone Breast Implant Restrictions Stand, FDA Tells Petitioners

November 7, 1997

UT System (Again) Directs DePinho to Cure MD Anderson Faculty Angst

November 7, 2014

NCCS Networker Volume 1 Issue 1, March 1987

March 12, 1987

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

October 28, 1994

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Six Panels To Help NCI Identify Progress; NCINews Roundup

January 8, 1993